Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT00942006
Other study ID # LNB-doxy-ceftriaxone
Secondary ID
Status Not yet recruiting
Phase N/A
First received July 17, 2009
Last updated July 17, 2009
Start date July 2009
Est. completion date November 2011

Study information

Verified date July 2009
Source University Medical Centre Ljubljana
Contact Katarina Ogrinc, MD PhD
Phone +386 1 522 4217
Email katarina.ogrinc1@guest.arnes.si
Is FDA regulated No
Health authority Slovenia: Ethics Committee
Study type Interventional

Clinical Trial Summary

The investigators will compare doxycycline and ceftriaxone in treatment of patients with suspected early Lyme neuroborreliosis and normal CSF cell count. The study hypothesis is that the efficacy and adverse effects of both antibiotics are comparable.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date November 2011
Est. primary completion date November 2010
Accepts healthy volunteers No
Gender Both
Age group 15 Years and older
Eligibility Inclusion Criteria:

- age >15 years

- erythema migrans in 4 months period before neurologic symptoms

- normal CSF cell count

- absence of more defined clinical symptoms or signs for CNS involvement (radicular pain, meningeal signs, peripheral facial palsy).

Exclusion Criteria:

- pregnancy

- lactation

- allergy on doxycycline and ceftriaxone

- immune deficiency.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
doxycycline
100 mg bid, 14 days
ceftriaxone
2g x 1 iv, 14 days

Locations

Country Name City State
Slovenia UMC Ljubljana, Department of Infectious Diseases Ljubljana

Sponsors (1)

Lead Sponsor Collaborator
University Medical Centre Ljubljana

Country where clinical trial is conducted

Slovenia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Objective sequelae and post-treatment subjective symptoms in patients treated for suspected early Lyme neuroborreliosis with normal CSF cell count with doxycycline or ceftriaxone for 14 days. 1 year follow-up Yes